» NEWS CATEGORIES » 340B

HHS on Wednesday (Sept. 22) asked the HHS Inspector General to investigate six drug companies that restrict 340B discounts to pharmacies with which hospitals contract. The move, which could result in fines, is the Health Resources and Services Administration’s latest gambit to get drug companies to comply with its interpretation of a vague law, this […]

Read More

The Supreme Court on Friday (July 2) agreed to hear arguments on hospitals’ lawsuit over cuts to Medicare reimbursement for 340B drugs — but on top of the question that hospitals asked it to look at, the court also wants to hear arguments on whether the issue is one that the judges could review or […]

Read More

The Supreme Court agreed Friday to hear a case challenging cuts the Department of Health and Human Services made to Medicare prescription-drug reimbursements for hospitals that serve low-income and underserved communities. The American Hospital Association (AHA) and the Association of American Medical Colleges (AAMC), which filed the petition to the high court with various hospital and health […]

Read More

A federal judge will not dismiss AstraZeneca’s case against a 340B advisory opinion involving contract pharmacies, even though HHS withdrew that opinion, because HHS still plans to enforce the policy that was the subject of the withdrawn advisory opinion, according to a memorandum order issued Wednesday (June 30) by the U.S. District Court for the […]

Read More